CLS (LON:CLI) Receives “Buy” Rating from Liberum Capital

Share on StockTwits

Liberum Capital reissued their buy rating on shares of CLS (LON:CLI) in a research note published on Wednesday, ThisIsMoney.Co.Uk reports.

Several other equities analysts have also commented on the stock. Peel Hunt reaffirmed a buy rating on shares of CLS in a research report on Wednesday, November 13th. Berenberg Bank reissued a buy rating and set a GBX 275 ($3.59) price target on shares of CLS in a research report on Thursday, September 5th.

Shares of CLS stock traded down GBX 3.50 ($0.05) during midday trading on Wednesday, hitting GBX 257 ($3.36). The company had a trading volume of 50,353 shares, compared to its average volume of 117,533. The stock has a market cap of $1.05 billion and a price-to-earnings ratio of 7.98. The company has a quick ratio of 1.05, a current ratio of 2.18 and a debt-to-equity ratio of 82.33. The company has a fifty day simple moving average of GBX 252.56 and a 200 day simple moving average of GBX 234.60. CLS has a 12-month low of GBX 195 ($2.55) and a 12-month high of GBX 271.50 ($3.55).

In other CLS news, insider Bengt F. Mortstedt sold 322,150 shares of the firm’s stock in a transaction that occurred on Thursday, October 17th. The shares were sold at an average price of GBX 259 ($3.38), for a total transaction of £834,368.50 ($1,090,250.23). Also, insider Bengt F. Mortstedt sold 172,045 shares of the firm’s stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of GBX 261 ($3.41), for a total transaction of £449,037.45 ($586,746.96).

About CLS

CLS Holdings plc, together with its subsidiaries, engages in the investment, development, and management of commercial properties in the United Kingdom, France, Germany, and France. It operates in two segments, Investment Property and Other Investments. The company also invests a hotel; and corporate bonds, shares, and other corporate investments.

Read More: Inverted Yield Curve

Receive News & Ratings for CLS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CLS and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.